Eating more protein helps protect muscle mass while taking GLP-1 medications like semaglutide
Among patients with fibrotic MASH, 95% were already eligible because of obesity-related conditions, high-risk type 2 diabetes, or both, while only 5% qualified solely under the new liver disease indication
The complex interaction of factors such as insulin resistance, glucotoxicity and lipotoxicity contribute to the pathogenesis and coexistence of diabetes and metabolic-dysfunction associated steatotic liver disease (MASLD) in a reciprocal process of exacerbating the underlying conditions [9]
Modelos de diabetes tipo 2 (db/db, ob/ob, ZDF) para caracterizar reduccin de HbA1c, glucemia en ayuno y funcin -pancretica
Their use does not imply endorsement by, affiliation with, or sponsorship by the trademark holders